Skip to main content
SpringerLink
Log in

Chronic lymphocytic leukemia developing in a patient with Janus kinase 2 V617F mutation positive myeloproliferative neoplasm

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Murugesan G, Aboudola S, Szpurka H et al (2006) Identification of the JAK2 V617F mutation in chronic myeloproliferative disorders using FRET probes and melting curve analysis. Am J Clin Pathol 125(4):625–633

    PubMed  CAS  Google Scholar 

  2. Levine RL, Loriaux M, Huntly BJ et al (2005) The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia. Blood 106(10):3377–3379

    Article  PubMed  CAS  Google Scholar 

  3. Kodali S, Chen C, Rathnasabapathy C et al (2009) JAK2 mutation in a patient with CLL with coexistent myeloproliferative neoplasm (MPN). Leuk Res 33(12):e236–e239

    Article  PubMed  CAS  Google Scholar 

  4. Larsen TS, Christensen JH, Hasselbalch HC et al (2007) The JAK2 V617F mutation involves B- and T-lymphocyte lineages in a subgroup of patients with Philadelphia-chromosome negative chronic myeloproliferative disorders. Br J Haematol 136(5):745–751

    Article  PubMed  CAS  Google Scholar 

  5. Ishii T, Bruno E, Hoffman R et al (2006) Involvement of various hematopoietic-cell lineages by the JAK2V617F mutation in polycythemia vera. Blood 108(9):3128–3134

    Article  PubMed  CAS  Google Scholar 

  6. Hussein K, Brakensiek K, Ballmaier M et al (2006) B-CLL developing in a patient with PV is not affected by V617F mutation of the Janus kinase 2. Eur J Haematol 77(6):539–541

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University, Kocamustafapasa, Fatih, Istanbul, Turkey

    Ahmet Emre Eskazan, Ayse Salihoglu & Teoman Soysal

  2. Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Istanbul Bilim University, Istanbul, Turkey

    Reyhan Diz-Kucukkaya

  3. Department of Medical Biology and Genetics, Faculty of Medicine, Istanbul Bilim University, Istanbul, Turkey

    Veysel Sabri Hancer

Authors
  1. Ahmet Emre Eskazan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ayse Salihoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Reyhan Diz-Kucukkaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Veysel Sabri Hancer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Teoman Soysal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ahmet Emre Eskazan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eskazan, A.E., Salihoglu, A., Diz-Kucukkaya, R. et al. Chronic lymphocytic leukemia developing in a patient with Janus kinase 2 V617F mutation positive myeloproliferative neoplasm. Ann Hematol 91, 305–306 (2012). https://doi.org/10.1007/s00277-011-1256-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-011-1256-6

Keywords

Search

Navigation